Seeking Alpha

Abbott Labs (ABT -0.1%) reaches an $800M settlement with the government to resolve all...

Abbott Labs (ABT -0.1%) reaches an $800M settlement with the government to resolve all outstanding issues regarding an investigation of past sales and marketing practices relating to its neurologic medication Depakote. The settlement stems from a four-year-old investigation into past sales activities, dating as far back as 1998. Additionally, the pharmaceutical giant says it will split into two separately traded companies.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs